DEVELOPMENT AND VALIDATION OF ACCEPTANCE AND COMMITMENT THERAPY (ACT): A COMPREHENSIVE REVIEW OF THEORETICAL FOUNDATIONS, EMPIRICAL EVIDENCE, AND CLINICAL APPLICATIONS
Genetics and Molecular Research · 25.06.2026
DOI: 10.4238/e96vdz61 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 25.06.2026. Verfasst von Ranjana Pal und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Acceptance and Commitment Therapy (ACT) represents a clinically significant evolution within the broader tradition of cognitive behavioural therapies, distinguished by its transdiagnostic functional focus rather than a syndrome-specific symptom-reduction orientation. Over four decades since its conceptual genesis, ACT has accumulated a substantial body of theoretical elaboration, measurement innovation, and empirical scrutiny that positions it among the most thoroughly evaluated third-wave psychotherapy frameworks. The present manuscript undertakes a comprehensive examination of ACT's development and validation trajectory, spanning its philosophical underpinnings in functional contextualism, the foundational role of Relational Frame Theory (RFT) in accounting for human suffering, the structural elaboration of the hexaflex model, the sequential expansion of evidence-based outcomes, and the cross-cultural and technological adaptations that have broadened its reach. Measurement development efforts, including the Acceptance and Action Questionnaire-II (AAQ-II), the Cognitive Fusion Questionnaire (CFQ), and the Valuing Questionnaire (VQ are reviewed with attention to their psychometric properties and role in process-based validation. Meta-analytic evidence from over 300 randomised controlled trials (RCTs) is synthesised, demonstrating medium-to-large effect sizes (Cohen's g = 0.55–0.82) across depressive, anxiety, chronic pain, and occupational stress conditions, with psychological flexibility consistently emerging as the central mechanism of change. Challenges related to the standardisation of protocol delivery, training fidelity, and equitable access across populations are discussed, along with directions for future third-generation ACT research. The cumulative evidence supports ACT's designation as an empirically supported treatment and underscores the value of theory-driven, process-focused validation methodology in clinical psychology.
Zitieren
APA
Pal, R., & Vashist, P. D. S. (2026). DEVELOPMENT AND VALIDATION OF ACCEPTANCE AND COMMITMENT THERAPY (ACT): A COMPREHENSIVE REVIEW OF THEORETICAL FOUNDATIONS, EMPIRICAL EVIDENCE, AND CLINICAL APPLICATIONS. Genetics and Molecular Research. https://doi.org/10.4238/e96vdz61
Vancouver
Pal R, Vashist PDS. DEVELOPMENT AND VALIDATION OF ACCEPTANCE AND COMMITMENT THERAPY (ACT): A COMPREHENSIVE REVIEW OF THEORETICAL FOUNDATIONS, EMPIRICAL EVIDENCE, AND CLINICAL APPLICATIONS. Genetics and Molecular Research. 2026. doi:10.4238/e96vdz61
BibTeX
@article{Pal2026,
author = {Pal, Ranjana and Vashist, Prof. (Dr.) Suman},
title = {DEVELOPMENT AND VALIDATION OF ACCEPTANCE AND COMMITMENT THERAPY (ACT): A COMPREHENSIVE REVIEW OF THEORETICAL FOUNDATIONS, EMPIRICAL EVIDENCE, AND CLINICAL APPLICATIONS},
journal = {Genetics and Molecular Research},
year = {2026},
doi = {10.4238/e96vdz61}
}
EUVIMED